Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In the United States, the Food and Drug Administration (FDA) classified BPC-157 as Category 2 for compounding due to adverse immune system reactions, peptide-related impurities and insufficient safety information to determine whether it would cause harm when administered to humans
Most meta-analyses found inverse associations between cruciferous vegetable intake and risk of bladder, breast, colorectal, endometrial, gastric, lung, ovarian, pancreatic, prostate, and renal cancer
NOT for human consumption, NOT for veterinary use, NOT a prescription medicine, and NOT intended for application in or on the body
Whether you are new to GHK-Cu or looking to optimise an existing protocol, working with a specialist ensures you are getting the most from the research
US$ 24.77
US$ 23.08
US$ 27.08
US$ 23.15
US$ 21.20
US$ 24.49
US$ 25.06
